美股異動 | 諾瓦瓦克斯醫藥(NVAX.US)快速拉昇漲超3% FDA批准其疫苗作為成年人序貫加強針接種

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

美股異動 | 諾瓦瓦克斯醫藥(NVAX.US)快速拉昇漲超3% FDA批准其疫苗作為成年人序貫加強針接種

格隆匯 10-19 23:11

格隆匯10月19日丨諾瓦瓦克斯醫藥(NVAX.US)快速拉昇漲超3%，報19.18美元。美國食品和藥物管理局(FDA)已批准該公司的疫苗作為序貫加強針為成年人接種，包括接受輝瑞公司或Moderna公司注射作為主要系列的人。

Novavax, Inc.(NVAX.US)

Moderna(MRNA.US)

Relevant Stocks

Novavax, Inc.(NVAX.US)

Moderna(MRNA.US)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

美股異動 | 諾瓦瓦克斯醫藥(NVAX.US)快速拉昇漲超3% FDA批准其疫苗作為成年人序貫加強針接種

Services

About Us

Agreement Statement